Get the Stockscreener App
0.00
100.00%
-3.54
After Hours:
3.54
3.54
+
Sonoma Pharmaceuticals Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.
See More
Previous Close:
$3.54
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$6.26M
Revenue:
$14.91M
Net Income/Loss:
$-3.56M
P/E Ratio:
0.00
EPS:
-2.4593
Net Cash Flow:
$-1.37M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$3.7823
52-Week Range:
$0.00
$6.9199
Sonoma Pharmaceuticals Inc Stock (SNOA) Company Profile
Name
Sonoma Pharmaceuticals Inc
Sector
Phone
800-759-9305
Address
5445 CONESTOGA COURT, SUITE 150, BOULDER, CA
Compare SNOA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SNOA
Sonoma Pharmaceuticals Inc
|
0.00 | 6.26M | 14.91M | -3.56M | -1.37M | -2.4593 |
|
ZTS
Zoetis Inc
|
121.16 | 53.43B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.24 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.90 | 44.00B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
25.54 | 29.63B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
462.30 | 19.87B | 3.08B | 1.24B | 1.07B | 25.61 |
Sonoma Pharmaceuticals Inc Stock (SNOA) Latest News
Why Sonoma Pharmaceuticals Inc. (O8Z) stock appears on watchlistsPortfolio Gains Summary & Free Expert Verified Stock Movement Alerts - newser.com
Published on: 2025-11-13 16:04:34 - newser.com
What does recent volatility data suggest for Sonoma Pharmaceuticals Inc.New Guidance & Smart Money Movement Alerts - newser.com
Sonoma Pharmaceuticals Inc. stock volume spike explained2025 Trading Recap & Free Daily Entry Point Trade Alerts - newser.com
Is Sonoma Pharmaceuticals Inc. (O8Z) stock attractive post correctionWeekly Investment Recap & AI Based Buy and Sell Signals - newser.com
How Sonoma Pharmaceuticals Inc. (O8Z) stock stacks up against competitorsJuly 2025 Movers & Weekly High Return Opportunities - newser.com
Sonoma Pharmaceuticals (SNOA) Achieves Recognition for Reliefacy - GuruFocus
National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced - Bluefield Daily Telegraph
Sonoma Pharmaceuticals (NASDAQ: SNOA) receives Rosacea Society Seal for Reliefacyn Advanced - Stock Titan
What downside risks could hit Sonoma Pharmaceuticals Inc. (O8Z) stockTake Profit & Risk Controlled Stock Pick Alerts - newser.com
Does Sonoma Pharmaceuticals Inc. stock trade at a discount to peersQuarterly Portfolio Report & Weekly Watchlist for Hot Stocks - newser.com
How to interpret RSI for Sonoma Pharmaceuticals Inc. stockJuly 2025 Breakouts & AI Driven Stock Price Forecasts - newser.com
Predicting Sonoma Pharmaceuticals Inc. trend using moving averagesSwing Trade & Free Reliable Trade Execution Plans - newser.com
What analysts say about Sonoma Pharmaceuticals Inc stockEconomic Indicators Overview & Free Grow Wealth With Picks - earlytimes.in
How Sonoma Pharmaceuticals Inc. stock reacts to oil pricesDollar Strength & AI Enhanced Trading Alerts - newser.com
Sentiment analysis tools applied to Sonoma Pharmaceuticals Inc.Recession Risk & Safe Entry Point Identification - newser.com
Is Sonoma Pharmaceuticals Inc. stock in correction or buying zone2025 Technical Overview & Low Volatility Stock Recommendations - newser.com
How analysts revise price targets for Sonoma Pharmaceuticals Inc. (O8Z) stock2025 Volatility Report & Smart Allocation Stock Tips - newser.com
Intraday pattern recognizer results for Sonoma Pharmaceuticals Inc.Market Volume Summary & AI Enhanced Trading Alerts - newser.com
Sonoma Pharmaceuticals, Inc. (SNOA) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Sonoma Pharmaceuticals: A Turning Point as Quarterly Results Show Dramatic Growth - AD HOC NEWS
Why Sonoma Pharmaceuticals Inc. stock is favored by top institutionsJobs Report & Free AI Powered Buy and Sell Recommendations - newser.com
Sonoma Pharmaceuticals reports higher revenue - Longmont Times-Call
Sonoma Pharmaceuticals to Exhibit at MEDICA 2025 in Düsseldorf - ACCESS Newswire
Will Sonoma Pharmaceuticals Inc. stock attract more institutional investors2025 Stock Rankings & Safe Entry Trade Reports - newser.com
How Sonoma Pharmaceuticals Inc. (O8Z) stock responds to job market shiftsEarnings Beat & Risk Controlled Swing Trade Alerts - newser.com
Sonoma Pharmaceuticals Inc (SNOA): Technicals Say You should Hold - fostersleader.com
Is Sonoma Pharmaceuticals Inc. stock gaining market shareJuly 2025 Earnings & Fast Moving Stock Watchlists - newser.com
Sonoma Pharmaceuticals Inc Stock (SNOA) Financials Data
Revenue
Net Income
Cash Flow
EPS
7.61%
0.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):